Format

Send to

Choose Destination
PLoS Med. 2018 Aug 2;15(8):e1002631. doi: 10.1371/journal.pmed.1002631. eCollection 2018 Aug.

A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health.

Author information

1
Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
2
Maine-Dartmouth Family Medicine Residency Program, Augusta, Maine, United States of America.
3
Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Rockville, Maryland, United States of America.
4
National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
5
Kaiser Permanente, Oakland, California, United States of America.
6
Brigham and Women's Hospital, Broad Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
7
Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
8
Yale School of Medicine, New Haven, Connecticut, United States of America.
9
All of Us Research Program, National Institutes of Health, Bethesda, Maryland, United States of America.
10
Office of Disease Prevention, National Institutes of Health, Bethesda, Maryland, United States of America.
11
Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, United States of America.

Abstract

In a Policy Forum, Muin Khoury and colleagues discuss research on the clinical application of genome sequencing data.

PMID:
30071015
PMCID:
PMC6071954
DOI:
10.1371/journal.pmed.1002631
[Indexed for MEDLINE]
Free PMC Article

Conflict of interest statement

I have read the journal's policy and the authors of this manuscript have the following competing interests: RCG receives compensation for consultation from AIA, Helix, Ohana, Prudential, and Veritas and is cofounder, advisor, and equity holder in Genome Medical, Inc. MFM reports personal fees from Invitae and grants from Regeneron, outside the submitted work.

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center